ChenGuang Biotech Group Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 6,295.71 million compared to CNY 4,873.61 million a year ago. Net income was CNY 435.67 million compared to CNY 351.51 million a year ago.

Basic earnings per share from continuing operations was CNY 0.8177 compared to CNY 0.6651 a year ago.